The role of FAS-FASL pathway in maintaining a balance between cell survival and cell death as well as in immune homeostasis [29], along with our observed upregulation of FASL in fluvastatin-treated mice, suggest the potential involvement of immune environment in tumor growth inhibition seen with statin treatment that needs to be explored. The gene discussed is FAS; the disease is neoplasm.